SB
Insider selling
Stephane Bancel sold $28.7M of MRNA stock
Stephane Bancel, Chief Executive Officer of Moderna, Inc. (MRNA), sold 499,246 shares of MRNA stock worth $28.7M, per an SEC Form 4 filed Aug 7, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 5, 2026, 2 days before it was made public.
MRNA has moved +330.3% since the trade date, from $56.26 to $242.08 (Oct 20, 2026 close).
- Traded
- Aug 5, 2026
- Disclosed
- Aug 7, 2026
- Filing delay
- 2 days
- Price since
- +330.3%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More MRNA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.